Davis Schneider, Emergent BioSolutions Partner
Analysis based on 7 articles · First reported Apr 29, 2026 · Last updated Apr 29, 2026
The partnership between Emergent BioSolutions and Davis Schneider is expected to increase public awareness and potentially the demand for Naloxone, positively impacting Emergent BioSolutions' market position. This initiative also highlights a significant public health issue in Canada, which could lead to broader policy discussions and increased investment in addiction treatment and prevention.
Davis Schneider, a player for the Toronto Blue Jays, has partnered with Emergent BioSolutions, the manufacturer of Narcan (naloxone) nasal spray, to raise awareness about the drug's ability to reverse opioid overdoses. Schneider's older brother died of an opioid overdose in 2020, motivating him to become a paid spokesperson for the company. The partnership aims to reduce the stigma associated with opioid overdoses and encourage the public to carry naloxone kits, which are available for free in Canada. Data from the Canada — Public Health Agency of Canada and the Canada — Canadian Centre on Substance Abuse Act indicates a severe opioid crisis in Canada, with thousands of deaths that could potentially be prevented by timely naloxone administration. Schneider advocates for naloxone kits to be as readily available in public places as fire extinguishers or first-aid kits.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard